Abstract

PurposeCompared to a healthy population, the gut microbiota in type 2 diabetes presents with several unfavourable features that may impair glucose regulation. The aim of this study was to evaluate the prebiotic effect of inulin-type fructans on the faecal microbiota and short-chain fatty acids (SCFA) in patients with type 2 diabetes.MethodsThe study was a placebo controlled crossover study, where 25 patients (15 men) aged 41–71 years consumed 16 g of inulin-type fructans (a mixture of oligofructose and inulin) and 16-g placebo (maltodextrin) for 6 weeks in randomised order. A 4-week washout separated the 6 weeks treatments. The faecal microbiota was analysed by high-throughput 16S rRNA amplicon sequencing and SCFA in faeces were analysed using vacuum distillation followed by gas chromatography.ResultsTreatment with inulin-type fructans induced moderate changes in the faecal microbiota composition (1.5%, p = 0.045). A bifidogenic effect was most prominent, with highest positive effect on operational taxonomic units (OTUs) of Bifidobacterium adolescentis, followed by OTUs of Bacteroides. Significantly higher faecal concentrations of total SCFA, acetic acid and propionic acid were detected after prebiotic consumption compared to placebo. The prebiotic fibre had no effects on the concentration of butyric acid or on the overall microbial diversity.ConclusionSix weeks supplementation with inulin-type fructans had a significant bifidogenic effect and induced increased concentrations of faecal SCFA, without changing faecal microbial diversity. Our findings suggest a moderate potential of inulin-type fructans to improve gut microbiota composition and to increase microbial fermentation in type 2 diabetes.Trial registrationThe trial is registered at clinicaltrials.gov (NCT02569684).

Highlights

  • Advice on diet and physical activity are the cornerstones of treatment of type 2 diabetes for regulation of blood glucose and prevention of long-term complications

  • The intake of dietary fibre assessed with food frequency questionnaires (FFQ) at the first visit turned out to be higher than expected, as the evaluation of fibre intake at the screening was based on a simpler approach with questioning about how often a few certain food items were consumed and their portion sizes

  • Apart from a reported higher intake of dietary fibre, the participants characteristics seemed to be representative of patients with type 2 diabetes in Norway

Read more

Summary

Introduction

Advice on diet and physical activity are the cornerstones of treatment of type 2 diabetes for regulation of blood glucose and prevention of long-term complications. Dietary recommendations include a diet rich in dietary fibres [1]. Prebiotic fibres evade degradation in the small intestine and are fermented into short-chain fatty acids (SCFA) in the colon by presumed health promoting gut bacteria, stimulating their growth and activity [4]. The SCFA may act as signalling molecules by binding to receptors on the enteroendocrine cells, with the potential to increase postprandial secretion of gut hormones and improve regulation of blood glucose [7]. Increased production of SCFA, especially butyric acid, is considered favourable [8,9,10]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call